By
Drug Target Review2024-04-04T15:00:03
The compound 11c demonstrates an excellent safety profile and is an exciting advancement in liver disease management.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T09:00:00Z
2026-06-02T15:00:00
Sponsored by Danaher Life Sciences
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2025-09-18T12:00:00
Sponsored by Benchling
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud